201 related articles for article (PubMed ID: 23558072)
1. Values of circulating GPC-3 mRNA and alpha-fetoprotein in detecting patients with hepatocellular carcinoma.
Yao M; Yao DF; Bian YZ; Wu W; Yan XD; Yu DD; Qiu LW; Yang JL; Zhang HJ; Sai WL; Chen J
Hepatobiliary Pancreat Dis Int; 2013 Apr; 12(2):171-9. PubMed ID: 23558072
[TBL] [Abstract][Full Text] [Related]
2. Oncofetal antigen glypican-3 as a promising early diagnostic marker for hepatocellular carcinoma.
Yao M; Yao DF; Bian YZ; Zhang CG; Qiu LW; Wu W; Sai WL; Yang JL; Zhang HJ
Hepatobiliary Pancreat Dis Int; 2011 Jun; 10(3):289-94. PubMed ID: 21669573
[TBL] [Abstract][Full Text] [Related]
3. Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma.
Wang L; Yao M; Pan LH; Qian Q; Yao DF
Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):361-6. PubMed ID: 26256079
[TBL] [Abstract][Full Text] [Related]
4. Down-regulating glypican-3 expression: molecular-targeted therapy for hepatocellular carcinoma.
Dong Z; Yao M; Wang L; Yang J; Yao D
Mini Rev Med Chem; 2014; 14(14):1183-93. PubMed ID: 25553423
[TBL] [Abstract][Full Text] [Related]
5. Detection of α-fetoprotein and glypican-3 mRNAs in the peripheral blood of hepatocellular carcinoma patients by using multiple FQ-RT-PCR.
Yan D; He Q; Chen Y; Wang L; Zhang X
J Clin Lab Anal; 2011; 25(2):113-7. PubMed ID: 21438004
[TBL] [Abstract][Full Text] [Related]
6. Can Glypican3 be diagnostic for early hepatocellular carcinoma among Egyptian patients?
Abdelgawad IA; Mossallam GI; Radwan NH; Elzawahry HM; Elhifnawy NM
Asian Pac J Cancer Prev; 2013; 14(12):7345-9. PubMed ID: 24460300
[TBL] [Abstract][Full Text] [Related]
7. [Expression features of glypican-3 and its diagnostic and differential values in hepatocellular carcinoma].
Bian YZ; Yao DF; Zhang CG; Li SS; Wu W; Dong ZZ; Qiu LW; Yu DD
Zhonghua Gan Zang Bing Za Zhi; 2011 Apr; 19(4):260-5. PubMed ID: 21586223
[TBL] [Abstract][Full Text] [Related]
8. Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma.
Dong ZZ; Yao DF; Yao DB; Wu XH; Wu W; Qiu LW; Jiang DR; Zhu JH; Meng XY
World J Gastroenterol; 2005 Aug; 11(30):4655-60. PubMed ID: 16094705
[TBL] [Abstract][Full Text] [Related]
9. Expression characteristics and diagnostic value of annexin A2 in hepatocellular carcinoma.
Zhang HJ; Yao DF; Yao M; Huang H; Wu W; Yan MJ; Yan XD; Chen J
World J Gastroenterol; 2012 Nov; 18(41):5897-904. PubMed ID: 23139605
[TBL] [Abstract][Full Text] [Related]
10. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of hepatic igf-ii expression and monitored levels of circulating igf-ii mRNA in metastasis of hepatocellular carcinoma.
Qian J; Yao D; Dong Z; Wu W; Qiu L; Yao N; Li S; Bian Y; Wang Z; Shi G
Am J Clin Pathol; 2010 Nov; 134(5):799-806. PubMed ID: 20959664
[TBL] [Abstract][Full Text] [Related]
12. Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood.
Komeda T; Fukuda Y; Sando T; Kita R; Furukawa M; Nishida N; Amenomori M; Nakao K
Cancer; 1995 May; 75(9):2214-9. PubMed ID: 7536120
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of FOXQ1 oncogene overexpression in human hepatocellular carcinoma.
Wang W; He S; Ji J; Huang J; Zhang S; Zhang Y
Pathol Res Pract; 2013 Jun; 209(6):353-8. PubMed ID: 23623360
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of glypican-3 in patients with HBV-associated hepatocellular carcinoma after liver transplantation.
Cui X; Li Z; Gao PJ; Gao J; Zhu JY
Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):157-63. PubMed ID: 25865688
[TBL] [Abstract][Full Text] [Related]
15. GPC-HCC model: a combination of glybican-3 with other routine parameters improves the diagnostic efficacy in hepatocellular carcinoma.
Attallah AM; El-Far M; Omran MM; Abdelrazek MA; Attallah AA; Saeed AM; Farid K
Tumour Biol; 2016 Sep; 37(9):12571-12577. PubMed ID: 27380057
[TBL] [Abstract][Full Text] [Related]
16. Distinct diagnostic and prognostic values of Glypicans gene expression in patients with hepatocellular carcinoma.
Wang JY; Wang XK; Zhu GZ; Zhou X; Yao J; Ma XP; Wang B; Peng T
BMC Cancer; 2021 Apr; 21(1):462. PubMed ID: 33902495
[TBL] [Abstract][Full Text] [Related]
17. [Significance of glypican-3 mRNA expression in hepatocellular carcinoma tissues and peripheral blood cells].
Li BD; Zhao QC; Zhu YT; Zhang FQ; Dou KF
Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):458-62. PubMed ID: 16772080
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma.
Dong ZZ; Yao DF; Yao M; Qiu LW; Zong L; Wu W; Wu XH; Yao DB; Meng XY
Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):288-95. PubMed ID: 18522884
[TBL] [Abstract][Full Text] [Related]
19. Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma.
Matsumura M; Niwa Y; Kato N; Komatsu Y; Shiina S; Kawabe T; Kawase T; Toyoshima H; Ihori M; Shiratori Y
Hepatology; 1994 Dec; 20(6):1418-25. PubMed ID: 7527002
[TBL] [Abstract][Full Text] [Related]
20. Significance of detecting circulating hepatocellular carcinoma cells in peripheral blood of hepatocellular carcinoma patients by nested reverse transcription-polymerase chain reaction and its clinical value: a retrospective study.
Liu Y; Wang YR; Wang L; Song RM; Zhou B; Song ZS
Tumori; 2014; 100(5):536-40. PubMed ID: 25343549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
